Skip to content
GraphTheory.in

Harish Dureja

Maharshi Dayanand University RohtakIN
ORCID0000-0001-8336-1984
h-index
42

via OpenAlex

Citations
6,184

via OpenAlex

Publications
421

About

Harish Dureja is a researcher at Maharshi Dayanand University Rohtak. With over 190 published works spanning more than five decades, he has focused on various aspects of pharmaceutical research, including pharmacophore modeling, QSAR studies, and drug delivery systems. His work aims to predict and optimize the activity of molecules against specific targets.

Research areas

  • Medicine
  • Chemistry
  • Materials science
  • Pharmacology
  • Biology

Publications (421)

Sorted by most cited.

  1. Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives

    2021

    View DOI
    306 cites
  2. Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro

    2020

    View DOI
    150 cites
  3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations

    2021

    View DOI
    147 cites
  4. Current-status and applications of polysaccharides in drug delivery systems

    2021

    View DOI
    146 cites
  5. Cosmeceuticals: An emerging concept

    2005

    View DOI
    146 cites
  6. A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies

    2023

    View DOI
    124 cites
  7. CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

    2021

    View DOI
    124 cites
  8. Nanoemulsion: A Novel Drug Delivery Approach for Enhancement of Bioavailability

    Recent Patents on Nanotechnology2020journal article

    View DOI
    109 cites
  9. Unlocking the secrets: Volatile Organic Compounds (VOCs) and their devastating effects on lung cancer

    2024

    View DOI
    99 cites
  10. Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: Breakthroughs and bottlenecks

    2021

    View DOI
    98 cites
  11. Developments in nutraceuticals

    2003

    90 cites
  12. An Overview of Vaccine Development for COVID-19

    2021

    View DOI
    77 cites
  13. Simulation of skin permeability in chitosan membranes

    International Journal of Pharmaceutics1970journal article

    View DOI
    74 cites
  14. 69 cites
  15. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review

    2023

    View DOI
    66 cites
  16. Molecular mechanisms of action of naringenin in chronic airway diseases

    European Journal of Pharmacology1970journal article

    View DOI
    65 cites
  17. Antiproliferative Effects of Boswellic acid-loaded Chitosan Nanoparticles on Human Lung Cancer Cell Line A549

    2020

    View DOI
    62 cites
  18. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection

    2020

    View DOI
    61 cites
  19. Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases

    2021

    View DOI
    60 cites
  20. 60 cites
  21. Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices

    2020

    View DOI
    59 cites
  22. 53 cites
  23. THERAPIES IN CANCER TREATMENT: AN OVERVIEW

    2015

    50 cites
  24. Development of novel multifunction directly compressible co-processed excipient by melt granulation technique

    International Journal of Pharmaceutical Investigation1970journal article

    View DOI
    48 cites
  25. Vitamin D—A prominent immunomodulator to prevent <scp>COVID</scp>‐19 infection

    2022

    View DOI
    47 cites
  26. Protein and peptide delivery to lungs by using advanced targeted drug delivery

    2021

    View DOI
    47 cites
  27. Effects of Curcumin-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles in MDA-MB231 Human Breast Cancer Cells

    2021

    View DOI
    47 cites
  28. Potential of nanoemulsions for accelerated wound healing: innovative strategies

    2023

    View DOI
    46 cites
  29. Nanocarriers: more than tour de force for thymoquinone

    Expert Opinion on Drug Delivery1970journal article

    View DOI
    46 cites
  30. Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics

    2024

    View DOI
    42 cites
  31. Bromelain: a review of its mechanisms, pharmacological effects and potential applications

    2023

    View DOI
    42 cites
  32. Nanosponges –a promising novel drug delivery system

    Recent Patents on Nanotechnology1970journal article

    View DOI
    41 cites
  33. Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases

    2022

    View DOI
    40 cites
  34. The Viral Capsid As Novel Nanomaterials for Drug Delivery

    2021

    View DOI
    40 cites
  35. Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression

    2021

    View DOI
    37 cites
  36. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation

    2024

    View DOI
    36 cites
  37. CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis

    2024

    View DOI
    36 cites
  38. Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases

    2023

    View DOI
    36 cites
  39. Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration

    2024

    View DOI
    34 cites
  40. Recent patents and patented technology platforms for pharmaceutical taste masking

    Recent Patents on Drug Delivery and Formulation1970journal article

    View DOI
    34 cites
  41. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices

    2024

    View DOI
    33 cites
  42. Co-processed excipients: A patent review

    Recent Patents on Drug Delivery and Formulation1970journal article

    View DOI
    33 cites
  43. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects

    2021

    View DOI
    32 cites
  44. Multivariate Data Analysis and Central Composite Design-Oriented Optimization of Solid Carriers for Formulation of Curcumin-Loaded Solid SNEDDS: Dissolution and Bioavailability Assessment

    2022

    View DOI
    31 cites
  45. Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies

    2021

    View DOI
    29 cites
  46. Rutin-Loaded Liquid Crystalline Nanoparticles Attenuate Oxidative Stress in Bronchial Epithelial Cells: A PCR Validation

    2021

    View DOI
    29 cites
  47. ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease

    2024

    View DOI
    26 cites
  48. Nanomedicine advances in cancer therapy

    2020

    View DOI
    26 cites
  49. Emerging complexity and the need for advanced drug delivery in targeting Candida species

    Current Topics in Medicinal Chemistry1970journal article

    View DOI
    26 cites
  50. Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer Treatment

    2023

    View DOI
    25 cites
  51. Chitosan-based nano drug delivery system for lung cancer

    2023

    View DOI
    25 cites
  52. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis

    2022

    View DOI
    25 cites
  53. Advances in Pulmonary Drug Delivery Targeting Microbial Biofilms in Respiratory Diseases

    2021

    View DOI
    24 cites
  54. Classification models for safe drug molecules

    Methods in Molecular Biology1970book

    View DOI
    24 cites
  55. Drug delivery and testing via 3D printing

    2023

    View DOI
    23 cites
  56. Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities

    2021

    View DOI
    23 cites
  57. Therapeutic potential of artemisia vulgaris: An insight into underlying immunological mechanisms

    Journal of Environmental Pathology, Toxicology and Oncology1970journal article

    View DOI
    23 cites
  58. Recent patents on polymeric nanoparticles for cancer therapy

    Recent Patents on Nanotechnology1970journal article

    View DOI
    23 cites
  59. Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation

    2022

    View DOI
    22 cites
  60. Preparation and Evaluation of Gefitinib Containing Nanoliposomal Formulation for Lung Cancer Therapy

    2022

    View DOI
    21 cites
  61. Role of Serine/Threonine Kinase 11 (STK11) or liver kinase B1 (LKB1) Gene in Peutz-Jeghers Syndrome

    Critical Reviews in Eukaryotic Gene Expression1970journal article

    View DOI
    21 cites
  62. Therapeutic approaches targeting aging and cellular senescence in Huntington's disease

    2024

    View DOI
    20 cites
  63. Global Trends of Cosmeceutical in Nanotechnology: A Review

    2023

    View DOI
    20 cites
  64. Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms

    2021

    View DOI
    20 cites
  65. Harnessing the neuroprotective effect of oral administration of benfotiamine in MPTP induced Parkinson's disease in rats

    2023

    View DOI
    19 cites
  66. Role of Nanotechnology in Diabetic Management

    Recent patents on nanotechnology1970journal article

    View DOI
    19 cites
  67. Neurodegenerative diseases and brain delivery of therapeutics: Bridging the gap using dendrimers

    2023

    View DOI
    18 cites
  68. Sorafenib tosylate loaded superparamagnetic nanoparticles: Development, optimization and cytotoxicity analysis on HepG2 human hepatocellular carcinoma cell line

    2022

    View DOI
    18 cites
  69. Targeting LIN28: A New Hope in Prostate Cancer Theranostics

    2021

    View DOI
    18 cites
  70. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery

    2015

    View DOI
    18 cites
  71. Solid dispersion adsorbates for enhancement of dissolution rates of drugs.

    2007

    18 cites
  72. Product lifecycle management in pharmaceuticals

    Journal of Medical Marketing1970journal article

    View DOI
    18 cites
  73. Nanomedicine-based approaches for delivery of herbal compounds

    2022

    View DOI
    17 cites
  74. 17 cites
  75. Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance

    2020

    View DOI
    17 cites
  76. Topochemical models for the prediction of permeability through blood-brain barrier

    International Journal of Pharmaceutics1970journal article

    View DOI
    17 cites
  77. Nanostructured materials used in drug delivery

    2022

    View DOI
    16 cites
  78. RETRACTED: SBracing NK cell based therapy to relegate pulmonary inflammation in COVID-19

    2021

    View DOI
    16 cites
  79. Topochemical models for the prediction of lipophilicity of 1,3-disubstituted propan-2-one analogs

    Journal of Theoretical and Computational Chemistry1970journal article

    View DOI
    16 cites
  80. Deciphering NF-κB pathways in smoking-related lung carcinogenesis

    2024

    View DOI
    15 cites
  81. Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges

    2024

    View DOI
    15 cites
  82. Recent Patents, Formulation and Characterization of Nanoliposomes

    2015

    View DOI
    15 cites
  83. Going beyond antibiotics: natural plant extracts as an emergent strategy to combat biofilm-associated infections

    Journal of Environmental Pathology, Toxicology and Oncology1970journal article

    View DOI
    15 cites
  84. Product lifecycle management through patents and regulatory strategies

    Journal of Medical Marketing1970journal article

    View DOI
    15 cites
  85. Enhancing the oral bioavailability offisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeteddelivery

    2024

    View DOI
    14 cites
  86. Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications

    2020

    View DOI
    14 cites
  87. Formulation and Characterization of Solid Dispersions of Glimepiride through Factorial Design

    2011

    14 cites
  88. Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases

    2023

    View DOI
    13 cites
  89. Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches

    2022

    View DOI
    13 cites
  90. Nanoemulsion for delivery of anticancer drugs

    2022

    View DOI
    13 cites
  91. Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters

    2020

    View DOI
    13 cites
  92. Induction of Caspase-Mediated Apoptosis in HepG2 Liver Carcinoma Cells Using Mutagen–Antioxidant Conjugated Self-Assembled Novel Carbazole Nanoparticles and In Silico Modeling Studies

    2020

    View DOI
    13 cites
  93. Interferon therapy for preventing COPD exacerbations

    2020

    View DOI
    13 cites
  94. 13 cites
  95. Role of Boswellic acids in cancer treatment

    Journal of Medical Sciences (Faisalabad)1970journal article

    View DOI
    13 cites
  96. Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization

    2023

    View DOI
    12 cites
  97. Magnetosomes: A Tool for Targeted Drug Delivery in the Management of Cancer

    2022

    View DOI
    12 cites
  98. Emerging cases of mucormycosis under <scp>COVID</scp>‐19 pandemic in India: Misuse of antibiotics

    2021

    View DOI
    12 cites
  99. Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and <i>In Vitro</i> Drug Release Studies

    2021

    View DOI
    12 cites
  100. Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer

    2021

    View DOI
    12 cites
  101. Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Antitubercular Drugs in Solid Lipid Nanoparticles

    2018

    View DOI
    12 cites
  102. AMYLOSE RICH STARCH AS AN AQUEOUS BASED PHARMACEUTICAL COATING MATERIAL - REVIEW

    2011

    View DOI
    12 cites
  103. Current biological and pharmacological updates on wogonin

    EXCLI Journal; 19:Doc635; ISSN 1611-21561970journal article

    View DOI
    12 cites
  104. 18-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migration

    2024

    View DOI
    11 cites
  105. Overcoming hydrolytic degradation challenges in topical delivery: non-aqueous nano-emulsions

    2021

    View DOI
    11 cites
  106. Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113

    2020

    View DOI
    11 cites
  107. 11 cites
  108. Erlotinib: A targeted anticancer drug

    Current Cancer Therapy Reviews1970journal article

    View DOI
    11 cites
  109. Enhancing the Therapeutic Potential of Nanomedicines by Modifying SurfaceCharacteristics

    2022

    View DOI
    10 cites
  110. Emerging Nanotechnology in Chronic Respiratory Diseases

    2020

    View DOI
    10 cites
  111. Co-Processed Excipients: A Patent Review

    2012

    View DOI
    10 cites
  112. Formulation and evaluation of metformin oro-dispersible tablets.

    2011

    10 cites
  113. 10 cites
  114. Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies

    2025

    View DOI
    9 cites
  115. Formulation and optimization of fisetin nanoemulsion for the treatment of Alzheimer's disease in rats: Pharmacokinetic and pharmacodynamic assessment

    2024

    View DOI
    9 cites
  116. Exploring the role of antibiotics and steroids in managing respiratory diseases

    2022

    View DOI
    9 cites
  117. Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design

    2022

    View DOI
    9 cites
  118. Expanding arsenal against diabetes mellitus through nanoformulations loaded with glimepiride and simvastatin: A comparative study

    2022

    View DOI
    9 cites
  119. Biological databases and tools for neurological disorders

    2022

    View DOI
    9 cites
  120. Calcium sensing receptor hyperactivation through viral envelop protein E of <scp>SARS CoV2</scp>: A novel target for cardio‐renal damage in <scp>COVID</scp>‐19 infection

    2021

    View DOI
    9 cites
  121. Prediction of Pharmacokinetic Parameters

    2012

    View DOI
    9 cites
  122. Implementation of Quality by Design: A Review

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2019journal article

    View DOI
    8 cites
  123. Partnership Efforts – Their Potential to Reduce the Challenges that Confront Regulators and Pharmaceutical Industry

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2019journal article

    View DOI
    8 cites
  124. Regulatory perspectives on medical device approval in global jurisdictions

    Journal of Generic Medicines1970journal article

    View DOI
    8 cites
  125. An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery

    2024

    View DOI
    7 cites
  126. Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and <i>in vitro</i> cytotoxicity study against human HepG2 carcinoma cells

    2023

    View DOI
    7 cites
  127. Nature bioinspired and engineered nanomaterials

    2022

    View DOI
    7 cites
  128. 505(b) (2) - A smart pathway to differentiate from competitive, low margin environment of generics

    2021

    View DOI
    7 cites
  129. Nanocelluloses as a Novel Vehicle for Controlled Drug Delivery

    2021

    View DOI
    7 cites
  130. Nanocelluloses in Sensing Technology

    2021

    View DOI
    7 cites
  131. PHARMACEUTICAL EXCIPIENTS: GLOBAL REGULATORYISSUES

    2013

    View DOI
    7 cites
  132. GLIPIZIDE : SOME ANALYTICAL, CLINICAL AND THERAPEUTIC VISTAS

    2010

    7 cites
  133. An Insight of Pulses: From Food to Cancer Treatment

    Journal of Pharmacognosy & Natural Products1970journal article

    View DOI
    7 cites
  134. Central composite designed boswellic acids loaded nanoparticles for enhanced cellular uptake in human lung cancer cell line A549

    2025

    View DOI
    6 cites
  135. Unravelling role of crocin for the treatment of Alzheimer’s and Parkinson’s disease: sojourn from food to nanomedicine

    2024

    View DOI
    6 cites
  136. Traditional Use, Phytochemistry and Pharmacology of Ananas comosus(L.) Merr.(Family Bromeliaceae): An Update

    2022

    View DOI
    6 cites
  137. Pulmonary Bioadhesive Drug Delivery Systems and Their Applications

    2020

    View DOI
    6 cites
  138. 6 cites
  139. 10. Liposomes: Preparations and Applications

    2012

    6 cites
  140. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment

    2024

    View DOI
    5 cites
  141. Nutraceuticals Unveiled a Multifaceted Neuroprotective Mechanisms for Parkinson’s Disease: Elixir for the Brain

    2024

    View DOI
    5 cites
  142. Orchestration of Obesolytic Activity of Microbiome: Metabiotics at Centre Stage

    2022

    View DOI
    5 cites
  143. Recent Trends in Rationally Designed Molecules as Kinase Inhibitors

    2021

    View DOI
    5 cites
  144. Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications

    2021

    View DOI
    5 cites
  145. Challenges and prospects in Chinese pharmaceutical regulatory environment

    Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector2020journal article

    View DOI
    5 cites
  146. 5 cites
  147. Formulation and optimization of xanthohumol loaded solid dispersion for effective treatment of Parkinson's disease in rats: In vitro and in vivo assessment

    2024

    View DOI
    4 cites
  148. Recent trends and applications of nanostructure-based drug delivery in alleviating pulmonary fibrosis

    2024

    View DOI
    4 cites
  149. Recent Trends and Applications of Nanostructure-based Drug Delivery in Alleviating Chronic Obstructive Pulmonary Disease (COPD)

    2024

    View DOI
    4 cites
  150. Therapeutic Application of Pineapple: A Review

    2023

    View DOI
    4 cites
  151. Introduction to Lung Disease

    2023

    View DOI
    4 cites
  152. Diagnosis and Clinical Aspects of Lung Cancer: A Special Emphasis onDrug Targeting to Cancer Cells through Nanoparticles

    2022

    View DOI
    4 cites
  153. Ananas comosus loaded nanoemulsion a promising therapeutic approach for cancer

    2022

    View DOI
    4 cites
  154. Role of traditional herbal medicine in treatment of malaria

    2022

    View DOI
    4 cites
  155. Recent Patents and Potential Applications of Homogenisation Techniquesin Drug Delivery Systems

    2021

    View DOI
    4 cites
  156. Formulation, Characterisation and In vitro Cytotoxic Effect of Lens culinaris Medikus Seeds Extract Loaded Chitosan Microspheres

    2021

    View DOI
    4 cites
  157. Current Trends in Phyto-cancer Therapy Using Nanoparticles

    Current Nanomedicine2019journal article

    View DOI
    4 cites
  158. Chromatographic methods used for characterization of boswellic acids

    MOJ Drug Design Development & Therapy2018journal article

    View DOI
    4 cites
  159. Pharma Emerging Market&#39;s Scaning by Look and Feel of its opportunities and Challenges

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2015journal article

    View DOI
    4 cites
  160. Cosmetic Regulations: A Comparative Study.

    2015

    4 cites
  161. Unravelling the role of nanomedicine in attenuating inflammation, oxidative stress and cellular ageing in chronic obstructive pulmonary disease

    2025

    View DOI
    3 cites
  162. Antibacterial Effects of Bioactive Boswellic Acids Loaded Chitosan Nanoparticles against Gram-Positive and Gram-Negative Bacteria

    2024

    View DOI
    3 cites
  163. Optimizing gefitinib nanoliposomes by Box-Behnken design and coating with chitosan: A sequential approach for enhanced drug delivery

    2024

    View DOI
    3 cites
  164. Cationic cycloamylose based nucleic acid nanocarriers

    2024

    View DOI
    3 cites
  165. Natural product-based antiinflammatory agents

    2023

    View DOI
    3 cites
  166. An updated review of pineapple and its bioactive compounds in breast cancer

    2023

    View DOI
    3 cites
  167. Emerging Applications of Polymeric Nanoparticles in Tumor Targeting

    2022

    View DOI
    3 cites
  168. Nanocelluloses as a Novel Vehicle for Controlled Drug Delivery

    2022

    View DOI
    3 cites
  169. Significance of and Challenges in Regulating Endocrine Disruptors – How Regulators and Industry can Conquer?

    Endocrine, Metabolic & Immune Disorders - Drug Targets2020journal article

    View DOI
    3 cites
  170. Erlotinib in Non-Small Cell Lung Cancer: From a thought to Necessity

    2019

    View DOI
    3 cites
  171. 3 cites
  172. Navigating the regulatory maze: a comparative analysis of digital therapeutics (DTx) regulations

    2025

    View DOI
    2 cites
  173. Lactoferrin-Conjugated Nanocarriers for Transformative Strategies inCancer Management: New Insights on Breast Cancer Therapy

    2025

    View DOI
    2 cites
  174. Nose to brain drug delivery through advanced drug delivery systems

    2024

    View DOI
    2 cites
  175. Exploring the Potential of Pectin for Gastro Retentive Drug Delivery Systems: From Orchard to Drug Delivery

    2024

    View DOI
    2 cites
  176. Selection of Design of PAT

    2024

    View DOI
    2 cites
  177. Correction to: Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases

    2022

    View DOI
    2 cites
  178. Nanocelluloses in Sensing Technology

    2022

    View DOI
    2 cites
  179. Vesicular Drug Delivery Systems in Respiratory Diseases

    2022

    View DOI
    2 cites
  180. Enhancement of Drug Dissolution of Erlotinib Tablets by Micronization Technique Using Pharmaceutical Experimental Design

    2021

    View DOI
    2 cites
  181. Comparative analysis of evolution of regulatory environment in USA, Europe and Japan

    2021

    View DOI
    2 cites
  182. Advancement in translational respiratory research using nanotechnology

    2020

    View DOI
    2 cites
  183. Box-Behnken Designed Nanoparticles-in-Microparticles System (NiMS) for Formulating Mouth Dissolving Tablets of Acetazolamide

    2014

    View DOI
    2 cites
  184. 2 cites
  185. Protein and peptide based nanotherapeutics for the management of Alzheimer’s disease: Current insights and future directions

    2025

    View DOI
    1 cites
  186. Optimization and Evaluation of Itopride Hydrochloride-Loaded Eudragit S100/Ethylcellulose Gastroretentive Electrospun Nanofibers for the Treatment of Gastroesophageal Reflux Disease

    2025

    View DOI
    1 cites
  187. Nanosuspension-based drug delivery system for management of diabetes and its complications: a review

    2025

    View DOI
    1 cites
  188. Dissolving microneedles as emerging tools in delivery of biological macromolecules: Current practices and future opportunities

    2025

    View DOI
    1 cites
  189. Clinical Trials and Regulatory Issues of Nanocarriers Employed in the Treatment of Chronic Obstructive Pulmonary Disease

    2025

    View DOI
    1 cites
  190. Regulations of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Inflammatory Diseases

    2025

    View DOI
    1 cites
  191. Nanostructure-Based Drug Delivery in Alleviating Type 2 Diabetes Mellitus

    2025

    View DOI
    1 cites
  192. Correction: Bromelain: a review of its mechanisms, pharmacological effects and potential applications

    2025

    View DOI
    1 cites
  193. Nanoemulsion-Based Nystatin Delivery: Formulation and Characterization Studies

    2024

    View DOI
    1 cites
  194. Recent Patents and Applications of Nanoemulsion and Nanoemulgel for Topical Drug Delivery

    2024

    View DOI
    1 cites
  195. Enhancing drug bioavailability for Parkinson's disease: The promise of chitosan delivery mechanisms

    2024

    View DOI
    1 cites
  196. Regulatory Aspects of Synbiotics-Based Delivery System

    2024

    View DOI
    1 cites
  197. Regulatory Considerations of Biosimilars in Cancer

    2024

    View DOI
    1 cites
  198. Polysaccharide-Based Nano-delivery Systems for the Treatment of Colorectal Cancer

    2024

    View DOI
    1 cites
  199. Nanotechnology in the Diagnosis of Allergic Airway Diseases

    2024

    View DOI
    1 cites
  200. Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

    2023

    View DOI
    1 cites
  201. Phytoligands analysis of aqueous seed extract of Momordica charantia Linn. via GC-MS for its antidiabetic activity

    2023

    View DOI
    1 cites
  202. Recent Insights into Osimertinib Analogues against EGFR PositiveNon-small Cell Lung Cancer

    2023

    View DOI
    1 cites
  203. Clinical Trials and Regulatory Issues of Natural Polymers Employed in Respiratory Disease

    2023

    View DOI
    1 cites
  204. Polymeric Nanoparticles-Based Drug Delivery Systems for Anticancer Therapy

    2023

    View DOI
    1 cites
  205. Chemical Moieties as Advanced Therapeutics for Targeting Respiratory Disorders

    2022

    View DOI
    1 cites
  206. Advanced drug delivery systems for targeting obesity

    2022

    View DOI
    1 cites
  207. Designing and Synthesis of Green Polymeric Nanomaterials for Pharmaceutical Applications

    2021

    View DOI
    1 cites
  208. Expanding Arsenal Against Diabetes Mellitus Through Nanoformulations Loaded With Glimepiride and Simvastatin: A Comparative Study

    2021

    View DOI
    1 cites
  209. Endocrine Disruptors (EDs) regulatory waves: A frictional lens perspective on regulated and emerging markets

    2021

    View DOI
    1 cites
  210. Advanced drug delivery system in pancreatic cancer

    2021

    View DOI
    1 cites
  211. Voicing regulatory perspectives of the combination products

    Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector2020journal article

    View DOI
    1 cites
  212. Classification Models Using Decision Tree, Random Forest, and Moving Average Analysis

    2020

    View DOI
    1 cites
  213. Randic Index and Its Variants: Applications

    2020

    View DOI
    1 cites
  214. Current and Future of Alzheimer's therapy with the best approach

    CNS & Neurological Disorders - Drug Targets2020journal article

    View DOI
    1 cites
  215. 1 cites
  216. Anticancer Drug-Loaded Nanoparticulate Drug Delivery

    2019

    View DOI
    1 cites
  217. ABC of Clinical Trials with the Mark of Safety, Efficacy and Transparency

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2017journal article

    View DOI
    1 cites
  218. Emerging Nutraceutical Regulations in India

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2017journal article

    View DOI
    1 cites
  219. Recent Advances in Nanotechnology based Tubercular Chemotherapy

    2015

    View DOI
    1 cites
  220. Panoramic View on Quality by Design

    2014

    View DOI
    1 cites
  221. Prediction of Antitumor Activity of N-(phenylsulfonyl)benzamides: Computational Approach using Topochemical Descriptors

    2008

    1 cites
  222. In Vitro Permeation Of Ionized And Unionized Diclofenac : Comparison Of Chitosan Membranes With Rat Skin

    2004

    1 cites
  223. Benzimidazoles withbiphenyls: Synthesis of 5- substituted - 2- n- propyl-1- [(2' - carboxybiphenyl-4-yl-) methyl] benzimidazoles

    2002

    1 cites
  224. Herbal product Development Perspective of Boerhavia diffusa: Challenges in Standardization and Regulation

    2026

    View DOI
    0 cites
  225. Retraction notice to "Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19" [Heliyon 7 (2021) e07635]

    2026

    View DOI
    0 cites
  226. Amalgamation of postbiotic, polysaccharide and plant flavonoid in nanostructured lipid carrier for treatment of rotenone-induced Parkinson's disease

    2025

    View DOI
    0 cites
  227. Recent Patents and Formulation Strategies for Osmotic Controlled Drug Delivery Systems: A Comprehensive Analysis.

    2025

    View DOI
    0 cites
  228. Synthetic Polymeric Materials-Based Drug Delivery Systems for Inflammatory Diseases

    2025

    View DOI
    0 cites
  229. Application of Self-Nanoemulsifying Drug Delivery Systems in Inflammatory Diseases

    2025

    View DOI
    0 cites
  230. Senolytics

    2025

    View DOI
    0 cites
  231. Preparation and Characterization of Pvp K30-Based Roflumilast Nanosuspension for Asthma and Chronic Obstructive Pulmonary Disease

    2025

    View DOI
    0 cites
  232. List of contributors

    2025

    View DOI
    0 cites
  233. Environmental toxicants

    2025

    View DOI
    0 cites
  234. Enhancing manufacturing efficiency with notch-enabled tooling: Cost-effective osmotically controlled release tablets using metformin HCl

    2025

    View DOI
    0 cites
  235. Contributors

    2024

    View DOI
    0 cites
  236. Quality by Design and Marketing

    2024

    View DOI
    0 cites
  237. An Update on Clinical Trials on Synbiotics

    2024

    View DOI
    0 cites
  238. Synbiotics: Complementary and Synergistic Approach Against Different Carcinomas

    2024

    View DOI
    0 cites
  239. Nanobiotechnology for Brain Tumor-Targeted Therapies

    2024

    View DOI
    0 cites
  240. Role of Pineapple and its Bioactive Compound Bromelain in COVID 19

    2023

    View DOI
    0 cites
  241. Elucidating the Molecular Mechanisms of Toxicity of Natural Polymer-Based Drug Delivery Systems Used in Various Pulmonary Disorders

    2023

    View DOI
    0 cites
  242. Contributors

    2023

    View DOI
    0 cites
  243. Synthesis, Self-Assembly, and Functional Chemistry of Amphiphilic Block Copolymers

    2023

    View DOI
    0 cites
  244. Polysaccharide-Based Nano-Delivery Systems for the Treatment of Colorectal Cancer

    2023

    View DOI
    0 cites
  245. Meet the Editorial Board Member

    2022

    View DOI
    0 cites
  246. Pharmacognostic, Phytochemical and Optimization Studies of Hydroalcoholic Extract of Terminalia catappa Linn. Dried Fruit

    2022

    View DOI
    0 cites
  247. Strategic archetype of Herbal Medicine Product (HMP) in Regulated and Emerging Market

    2022

    View DOI
    0 cites
  248. Three-Dimensional Printing: Future of Pharmaceutical Industry

    2022

    View DOI
    0 cites
  249. List of contributors

    2022

    View DOI
    0 cites
  250. Emerging drug delivery in the treatment of hyperpituitarism and hypopituitarism

    2022

    View DOI
    0 cites
  251. Advanced drug delivery systems targeting metabolic disorders: erythropoietic protoporphyria

    2022

    View DOI
    0 cites
  252. Advanced drug delivery system in the treatment of hyperglycemia and hypoglycemia

    2022

    View DOI
    0 cites
  253. An update review on drug repurposing for COVID-19

    2022

    View DOI
    0 cites
  254. 皮膚疾患治療のためのナノキャリア:原理,展望および実践【JST・京大機械翻訳】

    2021

    0 cites
  255. Exploring the Potential of Medicinal Plants in Lung Cancer

    2021

    View DOI
    0 cites
  256. Contributors

    2021

    View DOI
    0 cites
  257. Edible Pulses: Part of A Balanced Diet to Manage Cancer

    2020

    View DOI
    0 cites
  258. Topology-Based Molecular Descriptors: The Current Status

    2020

    View DOI
    0 cites
  259. Superaugmented Eccentric Connectivity Indices and Their Significance in Drug Discovery Process

    2020

    View DOI
    0 cites
  260. Pendentancy-Based Molecular Descriptors for QSAR/QSPR Studies

    2020

    View DOI
    0 cites
  261. Issue Information

    2020

    View DOI
    0 cites
  262. Preparation, optimisation and characterisation of letrozole nano-liposomes

    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH2020journal issue

    View DOI
    0 cites
  263. Magnetic Nanoparticles: Possibilities and Challenges

    2020

    0 cites
  264. 先端薬物送達システムはコロナウイルス疾患(COVID-19)を標的とすることができる:仮説【JST・京大機械翻訳】

    2020

    0 cites
  265. Contributors

    2020

    View DOI
    0 cites
  266. Acknowledgements to Reviewers

    2019

    0 cites
  267. Regulatory Traits - Relevance to Contemporary Healthcare Environment (Part-II)

    2019

    View DOI
    0 cites
  268. Phytochemical Analysis of Terminalia catappa Linn Fruit in Ethanolic Extract Using GC-MS,

    International Journal of Pharmacy and Pharmaceutical Research2019journal article

    0 cites
  269. Regulatory Traits - Relevance to Contemporary Healthcare Environment (Part-I)

    2019

    View DOI
    0 cites
  270. EFFECT OF CHITOSAN COATING ON THE PHYSIOCHEMICAL CHARACTERISTICS OF GEFITINIB LOADED NANOLIPOSOMES

    International Journal of Pharmaceutical Sciences and Research2018journal issue

    View DOI
    0 cites
  271. OPTIMIZING THE FORMULATION VARIABLES FOR ERLOTINIB LOADED CHITOSAN NANOPARTICLES

    International Journal of Pharmaceutical Sciences and Research2018journal issue

    View DOI
    0 cites
  272. []

    International Journal of Pharmaceutical Sciences and Research2018journal issue

    View DOI
    0 cites
  273. Editorial: Nanoparticulate Drug Delivery Systems

    2018

    View DOI
    0 cites
  274. SELF-MEDICATION IN RELATION TO HEALTH LOCUS OF CONTROL

    International Journal of Drug Regulatory Affairs2018journal article

    View DOI
    0 cites
  275. A PRAGMATIC WAY TO SUSTAIN IN GENERIC PHARMA ENVIRONMENT: PLCM THROUGH REGULATORY STRATEGIES

    International Journal of Drug Regulatory Affairs2018journal article

    View DOI
    0 cites
  276. Nanoparticulate Drug Delivery Systems

    2017

    0 cites
  277. Editorial: Regulatory Audit and Compliance in Life Science Domain

    2017

    View DOI
    0 cites
  278. Spray-Dried Microspheres of Roxithromycin for Formulating into Dispersible Tablets Using Central Composite Design

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2016journal article

    View DOI
    0 cites
  279. Editorial (Thematic Issue: Regulatory Stratagem in Health Care Environment - Need for Success)

    2015

    View DOI
    0 cites
  280. Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry

    2015

    View DOI
    0 cites
  281. Cosmetics: Regulatory Scenario in USA, EU and India

    JOURNAL OF PHARMACEUTICAL TECHNOLOGY, RESEARCH AND MANAGEMENT2015journal article

    View DOI
    0 cites
  282. Drug and Cosmetic Amendment Bill in India – a Promising Hope for Healthy Medical Device Regulatory Environment

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2015journal article

    View DOI
    0 cites
  283. Prospective of Pricing in Pharmaceutical Environment

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2015journal article

    View DOI
    0 cites
  284. Central Composite Designed Taste Masked Ion Exchange Resinates for Development of Azithromycin Dispersible Tablets

    2015

    View DOI
    0 cites
  285. []

    International Journal of Pharmaceutical Sciences and Research2014journal issue

    View DOI
    0 cites
  286. Big Pharma Recent Challenges

    Applied Clinical Research, Clinical Trials and Regulatory Affairs2014journal article

    View DOI
    0 cites
  287. Computation of models for prediction of blood brain barrier permeability using molecular descriptors

    2013

    View DOI
    0 cites
  288. Selection of color additives: a regulatory view.

    2012

    0 cites
  289. Development of mathematical models for prediction of biopharmaceutical biological and physicochemical properties of molecules

    2007

    0 cites
  290. Possible Involvement Of Stretch-Activated Channels In The Cardioprotective Effect Of Remote Aortic Preconditioning

    2005

    0 cites
  291. Cosmeceuticals: An emerging concept

    Indian Journal of Pharmacology1970journal article

    0 cites
  292. 0 cites
  293. Multivariate Optimization Tools in Pharmaceutical Process and Formulation Development,

    Drug development and delivery1970journal article

    0 cites
  294. Bar Code in Pharmaceutical Industry,

    Chronicle Pharmabiz1970magazine article

    0 cites
  295. Development of Olanzapine Melt-in-Mouth Tablets by Sublimation Technique,

    Journal of Pharmaceutical Research1970journal article

    0 cites
  296. Emerging uses of Chitosan- A Review,

    Journal of Sciences and Pharmacy1970journal article

    0 cites
  297. Formulation of Lamotrigine Oro-dispersible Tablets by Superdisintegrating Agents,

    The Indian Pharmacist1970journal article

    0 cites
  298. 0 cites
  299. Mouth dissolving tablets: A review

    Indian Drugs1970journal article

    0 cites
  300. Orally Disintegrating Tablets,

    Tablets and Capsules1970journal article

    0 cites
  301. Patents in Pharmaceuticals: An Indian Scenario,

    MDU Law Journal1970journal article

    0 cites
  302. Role of Community Pharmacist in Ensuring Better Healthcare-I,

    Chronicle Pharmabiz1970magazine article

    0 cites
  303. Role of Community Pharmacist in Ensuring Better Healthcare-II

    Chronicle Pharmabiz1970journal article

    0 cites
  304. Developments in nutraceuticals

    Indian Journal of Pharmacology1970journal article

    0 cites
  305. Regulatory Aspects of Dietary Supplements,

    Journal of Science and Pharmacy1970journal article

    0 cites
  306. Chitosan - Preparation and Properties,

    Indian Drugs1970journal article

    0 cites
  307. Permeability Evaluation of Transdermal Drug Delivery Systems,

    Journal of Science and Pharmacy1970journal article

    0 cites
  308. Microscopic Studies On Lens Culinaris Medikus Seeds Using Bright-Field Microscope And Polarized Light Microscope.

    Plant Archives1970journal article

    0 cites
  309. Antihypertensive drugs: Are they cost-effective?

    Asian Journal of Pharmaceutics1970journal article

    0 cites
  310. Antitubercular Drugs Loaded Solid Lipid Nanoparticles as a Potential Antimycobacterial Activity against M.smegmatis

    The Pharma Innovation Journal1970journal article

    0 cites
  311. Pharmacoeconomics of antidiabetic drugs

    Asian Journal of Pharmaceutics1970journal article

    0 cites
  312. Microspheres: A Reliable Drug Delivery System For Anticancer Herbal Drugs

    World Journal of Pharmaceutical Research1970journal article

    0 cites
  313. 0 cites
  314. Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry

    Applied Clinical Research, Clinical Trials and Regulatory Affairs1970journal article

    0 cites
  315. Central composite designed taste masked ion exchange resonates for development of azithromycin dispersible tablets,

    Journal of Pharmaceutical Research,1970journal article

    0 cites
  316. Cosmetic regulations: A comparative study

    SKINmed1970journal article

    0 cites
  317. Ion exchange resin complexation technique for pharmaceutical taste masking: an overview,

    World Journal of Pharmaceutical Research1970journal article

    0 cites
  318. Recent Advances in Nanotechnology Based Tubercular Chemotherapy,.

    International Journal of Pharmaceutical Sciences and Nanotechnology,1970journal article

    0 cites
  319. Recent Patents, Formulation and Characterization of Nanoliposomes

    Recent patents on drug delivery &amp; formulation1970journal article

    0 cites
  320. Recent patents, formulation and characterization of nanoliposomes

    Recent Patents on Drug Delivery and Formulation1970journal article

    0 cites
  321. 0 cites
  322. Taste masking of bitter pharmaceuticals by spray drying technique,

    Journal of Chemical and Pharmaceutical Research1970journal article

    0 cites
  323. Therapies in cancer treatment: An overview

    International Journal of Pharmacy and Pharmaceutical Sciences1970journal article

    0 cites
  324. Using a dual-drug resinate complex for taste masking

    Pharmaceutical Technology Europe1970journal article

    0 cites
  325. Box-Behnken Designed Fluconazole Loaded Chitosan Nanoparticles for Ocular Delivery

    Journal of Pharmaceutics & Drug Delivery Research1970journal article

    View DOI
    0 cites
  326. Box-Behnken Designed Nanoparticles-In-Microparticles System (Nims) For Formulating Mouth Dissolving Tablets of Acetazolamide,

    Journal of Pharmaceutical Research1970journal article

    0 cites
  327. Panaoramic view on Qualtiy by Design

    Journal of Pharm. Tech. Res. and Mgt.1970journal article

    0 cites
  328. Parijat Pandy and Harish Dureja, Nanoparticles-in-microparticles systems (NiMS): an overview,

    Journal of Innovative Biology1970journal article

    0 cites
  329. Computation of models for prediction of blood brain barrier permeability using molecular descriptors

    Journal of Computational Methods in Sciences and Engineering1970journal article

    View DOI
    0 cites
  330. Pharmaceutical Excipients: Global Regulatory Issues,

    1970journal article

    0 cites
  331. Fast Dissolving Tablets: an overview,

    Novel Science International Journal of Pharmaceutical Science,1970journal article

    0 cites
  332. Liposomes: Preparations and Applications,

    International Journal of Drug Development and Research1970journal article

    0 cites
  333. Prediction of pharmacokinetic parameters

    Methods in Molecular Biology1970book

    View DOI
    0 cites
  334. Prediction of pharmacokinetic parameters.

    Methods in molecular biology (Clifton, N.J.)1970journal article

    0 cites
  335. Selection of color additives: a regulatory view.

    International journal of pharmaceutical compounding1970journal article

    0 cites
  336. Amylose Rich Starch as an Aqueous Based Pharmaceutical Coating Material – Review,

    International Journal of Pharmaceutical Sciences and Drug Research1970journal article

    0 cites
  337. Clinical Trials in India: Current Regulatory and Ethical Overview

    Entire Research1970journal article

    0 cites
  338. Development and Characterization of Factorially Designed 5-Fluorouracil Microspheres .

    Bulletin of Pharmaceutical Research1970journal article

    0 cites
  339. Formulation and characterization of solid dispersions of glimepiride through factorial design

    Iranian Journal of Pharmaceutical Sciences1970journal article

    0 cites
  340. Formulation and evaluation of metformin oro-dispersible tablets

    Acta Poloniae Pharmaceutica - Drug Research1970journal article

    0 cites
  341. In Vitro Dissolution Profile Comparison: Prognostic tool for biowaivers based on BCS,

    Journal of Pharmaceutical Research1970journal article

    0 cites
  342. Decision tree and moving average analysis based models for prediction of BRAF inhibitory activity of 2, 6-disubstituted pyrazines,

    1970journal article

    0 cites
  343. Glipizide : Some analytical, clinical and therapeutic vistas,

    International Journal of Chemical Sciences,1970journal article

    0 cites
  344. Medicated Chewing Gums: A Potential Drug Delivery System

    1970journal article

    0 cites
  345. 0 cites
  346. Models for the Prediction of A3 Adenosine Receptor Binding Affinity of 2-Chloro-N6-Substituted-4´-Thioadenosine-5´-Uronamides

    International Journal of Chemical Modeling,1970journal article

    0 cites
  347. New Drug Approval Process: Regulatory View

    Pharmaceutical Reviews1970journal article

    0 cites
  348. 0 cites
  349. Floating drug delivery systems

    Asian Journal of Chemistry1970journal article

    0 cites
  350. Medical devices: A regulatory overview

    Pharmaceutical Reviews1970journal article

    0 cites
  351. Pharmacosomes: A potential alternative to conventional vesicular systems

    Pharmaceutical Technology1970journal article

    0 cites
  352. Development of Sustained Release Solid Dispersion using Factorial Design

    Drug Development and Delivery1970journal article

    0 cites
  353. Dureja Harish and Madan A. K., Prediction of Antitumor Activity of N-(Phenylsulfonyl)Benzamides: Computational Approach using Topochemical Descriptors,

    1970journal article

    0 cites
  354. Adsorption in Pharmacy: A Review,

    Drug Development and Delivery1970journal article

    0 cites
  355. Solid dispersion adsorbates for enhancement of dissolution rates of drugs

    PDA Journal of Pharmaceutical Science and Technology1970journal article

    0 cites
  356. ormulation and Evaluation of Controlled Release Matrix Tablets,

    Tablets and Capsules1970journal article

    0 cites
  357. Alternative Insulin Delivery Systems,

    Pharmaceutical Reviews1970journal article

    0 cites
  358. Nanoparticle technology for the delivery of poorly water-soluble drugs

    Pharmaceutical Technology1970journal article

    0 cites
  359. Near Infra-Red Spectroscopy,

    Tablets and Capsules1970journal article

    0 cites
  360. Aloe Vera,

    The Indian Pharmacist1970journal article

    0 cites
  361. An Introduction to Combinatorial Chemistry: A Rapid Approach to Lead Development,

    Pharmaceutical Reviews1970journal article

    0 cites
  362. Bar Code: An Overview

    Pharmaceutical Reviews1970journal article

    0 cites